Yahoo
NasdaqCM - Nasdaq Real Time Price USD

HeartBeam, Inc. (BEAT)

0.5500 +0.0111 (+2.06%)
At close: October 30 at 4:00:00 PM EDT
0.5549 +0.0049 (+0.89%)
After hours: October 30 at 7:53:30 PM EDT
Chart Range Bar
Loading chart for BEAT
  • Previous Close 0.5389
  • Open 0.5400
  • Bid 0.3875 x 100
  • Ask 0.6356 x 100
  • Day's Range 0.5200 - 0.5589
  • 52 Week Range 0.3550 - 4.0000
  • Volume 1,521,129
  • Avg. Volume 7,408,801
  • Market Cap (intraday) 30.992M
  • Beta (5Y Monthly) -0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5000
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 3.50
  • Zacks Rating Bullish

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

www.heartbeam.com

16

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BEAT
77.08%
S&P 500 (^GSPC)
10.73%

1-Year Return

BEAT
65.84%
S&P 500 (^GSPC)
11.11%

3-Year Return

BEAT
51.33%
S&P 500 (^GSPC)
81.91%

5-Year Return

BEAT
89.81%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -4.7M
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-5M
-4M
-3M
-2M
-1M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

2.00
3.50 Average
0.5500 Current
5.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/22/2026
Analyst HC Wainwright & Co.
Rating Action Downgrade
Rating Neutral
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -153.52%

  • Return on Equity (ttm)

    -328.44%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -20.3M

  • Diluted EPS (ttm)

    -0.5000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.72M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.56M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: